To include your compound in the COVID-19 Resource Center, submit it here.

Extending a Bold vision for Longevity

Why Bold Capital's Sergey Young is launching a discrete longevity fund

After making a handful of longevity-related investments as a partner at Bold Capital, Sergey Young is seeking to invest about $100 million via the Longevity Vision Fund, a new vehicle dedicated solely to the field of life extension technologies.

Young told BioCentury the fund has raised

Read the full 459 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers